10-K Filing

GUIDED THERAPEUTICS INC CIK: 924515 FY 2018

Filing Information

Form Type	10-K
Accession Number	`0001654954-19-005469`
Period End Date	20181231
Filing Date	20190508
Fiscal Year	2018
Fiscal Period	FY
XBRL Instance	gthp-20181231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 105 Income Statement 46 Cash Flow Statement 57 Stockholders Equity 17

Balance Sheet 105 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$160.00K	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$157.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$716.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$14.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$767.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $157 and $160 at December 31, 2018 and 2017, respectively	`AccountsReceivableNet`	$13.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $157 and $160 at December 31, 2018 and 2017, respectively	`AccountsReceivableNet`	$3.00K	USD	Point-in-time
Inventory, net of reserves of $767 and $716 at December 31, 2018 and 2017, respectively	`InventoryNet`	$114.00K	USD	Point-in-time
Inventory, net of reserves of $767 and $716 at December 31, 2018 and 2017, respectively	`InventoryNet`	$182.00K	USD	Point-in-time
Series C convertible preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Series C convertible preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Series C convertible preferred stock, authorized	`PreferredStockSharesAuthorized`	9.00	shares	Point-in-time
Series C convertible preferred stock, authorized	`PreferredStockSharesAuthorized`	9.00	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$69.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$111.00K	USD	Point-in-time
Series C convertible preferred stock, issued	`PreferredStockSharesIssued`	0.90	shares	Point-in-time
Total current assets	`AssetsCurrent`	$196.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$297.00K	USD	Point-in-time
Series C convertible preferred stock, issued	`PreferredStockSharesIssued`	0.90	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$49.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$21.00K	USD	Point-in-time
Series C convertible preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.90	shares	Point-in-time
Series C convertible preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.90	shares	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$60.00K	USD	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$19.00K	USD	Point-in-time
Series C convertible preferred stock, liquidation preference	`PreferredStockLiquidationPreferenceValue`	$970.00K	USD	Point-in-time
Series C convertible preferred stock, liquidation preference	`PreferredStockLiquidationPreferenceValue`	$286.00K	USD	Point-in-time
Series C1 convertible preferred stock, par value	`SeriesC1PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$109.00K	USD	Point-in-time
Series C1 convertible preferred stock, par value	`SeriesC1PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$40.00K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$406.00K	USD	Point-in-time
Series C1 convertible preferred stock, authorized	`SeriesC1PreferredStockSharesAuthorized`	20.30	shares	Point-in-time
Series C1 convertible preferred stock, authorized	`SeriesC1PreferredStockSharesAuthorized`	20.30	shares	Point-in-time
TOTAL ASSETS	`Assets`	$236.00K	USD	Point-in-time
Series C1 convertible preferred stock, issued	`SeriesC1PreferredStockSharesIssued`	4.30	shares	Point-in-time
Series C1 convertible preferred stock, issued	`SeriesC1PreferredStockSharesIssued`	4.30	shares	Point-in-time
Series C1 convertible preferred stock, outstanding	`SeriesC1PreferredStockSharesOutstanding`	4.30	shares	Point-in-time
Series C1 convertible preferred stock, outstanding	`SeriesC1PreferredStockSharesOutstanding`	4.30	shares	Point-in-time
Series C1 convertible preferred stock, liquidation preference	`SeriesC1PreferredStockLiquidationPreferenceValue`	$4.31M	USD	Point-in-time
Series C1 convertible preferred stock, liquidation preference	`SeriesC1PreferredStockLiquidationPreferenceValue`	$1.05M	USD	Point-in-time
Notes payable in default, including related parties	`ShortTermBorrowings`	$700.00K	USD	Point-in-time
Notes payable in default, including related parties	`ShortTermBorrowings`	$1.09M	USD	Point-in-time
Series C2 convertible preferred stock, par value	`SeriesC2PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Short-term notes payable, including related parties	`ShorttermNotesPayable`	$899.00K	USD	Point-in-time
Series C2 convertible preferred stock, par value	`SeriesC2PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Short-term notes payable, including related parties	`ShorttermNotesPayable`	$447.00K	USD	Point-in-time
Convertible note in default	`ConvertibleNotesPayableCurrent`	$2.78M	USD	Point-in-time
Series C2 convertible preferred stock, authorized	`SeriesC2PreferredStockSharesAuthorized`	5,000.00	shares	Point-in-time
Series C2 convertible preferred stock, authorized	`SeriesC2PreferredStockSharesAuthorized`	5,000.00	shares	Point-in-time
Convertible note in default	`ConvertibleNotesPayableCurrent`	$2.32M	USD	Point-in-time
Convertible notes payable, net	`NotesPayableCurrent`	$380.00K	USD	Point-in-time
Series C2 convertible preferred stock, issued	`SeriesC2PreferredStockSharesIssued`	0.00	shares	Point-in-time
Series C2 convertible preferred stock, issued	`SeriesC2PreferredStockSharesIssued`	3.30	shares	Point-in-time
Convertible notes payable, net	`NotesPayableCurrent`	$783.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.02M	USD	Point-in-time
Series C2 convertible preferred stock, outstanding	`SeriesC2PreferredStockSharesOutstanding`	3.30	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.01M	USD	Point-in-time
Series C2 convertible preferred stock, outstanding	`SeriesC2PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Series C2 convertible preferred stock, liquidation preference	`SeriesC2PreferredStockLiquidationPreferenceValue`	-	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$3.16M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$4.16M	USD	Point-in-time
Series C2 convertible preferred stock, liquidation preference	`SeriesC2PreferredStockLiquidationPreferenceValue`	$3.26M	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$21.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$66.00K	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	1.00M	shares	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$10.99M	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	1.00M	shares	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$11.85M	USD	Point-in-time
Warrants, at fair value	`WarrantsNotSettleableInCashFairValueDisclosure`	$4.73M	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	2,669.00	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	49,563.00	shares	Point-in-time
Warrants, at fair value	`WarrantsNotSettleableInCashFairValueDisclosure`	$7.96M	USD	Point-in-time
Long-term debt-related parties	`DueToRelatedPartiesNoncurrent`	$340.00K	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	61,954.00	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	2.67M	shares	Point-in-time
Long-term debt-related parties	`DueToRelatedPartiesNoncurrent`	-	USD	Point-in-time
Total long-term debt	`LongTermDebt`	$7.96M	USD	Point-in-time
Total long-term debt	`LongTermDebt`	$5.07M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$16.06M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$19.81M	USD	Point-in-time
COMMITMENTS & CONTINGENCIES (Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
COMMITMENTS & CONTINGENCIES (Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Series C convertible preferred stock, $.001 par value; 9.0 shares authorized, 0.3 and 0.9 shares issued and outstanding as of December 31, 2018 and 2017, respectively. (Liquidation preference of $286 and $970 at December 31, 2018 and 2017, respectively).	`ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue`	$105.00K	USD	Point-in-time
Series C convertible preferred stock, $.001 par value; 9.0 shares authorized, 0.3 and 0.9 shares issued and outstanding as of December 31, 2018 and 2017, respectively. (Liquidation preference of $286 and $970 at December 31, 2018 and 2017, respectively).	`ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue`	$355.00K	USD	Point-in-time
Series C1 convertible preferred stock, $.001 par value; 20.3 shares authorized, 1.0 and 4.3 shares issued and outstanding as of December 31, 2018 and 2017, respectively. (Liquidation preference of $1,049 and $4,312 at December 31, 2018 and 2017, respectively).	`ConvertiblePreferredStockSeriesC1NonredeemableOrRedeemableIssuerOptionValue`	$170.00K	USD	Point-in-time
Series C1 convertible preferred stock, $.001 par value; 20.3 shares authorized, 1.0 and 4.3 shares issued and outstanding as of December 31, 2018 and 2017, respectively. (Liquidation preference of $1,049 and $4,312 at December 31, 2018 and 2017, respectively).	`ConvertiblePreferredStockSeriesC1NonredeemableOrRedeemableIssuerOptionValue`	$701.00K	USD	Point-in-time
Series C2 convertible preferred stock, $.001 par value; 5,000 shares authorized, 3.3 and nil shares issued and outstanding as of December 31, 2018 and 2017, respectively. (Liquidation preference of $3,263 and nil at December 31, 2018 and 2017, respectively).	`ConvertiblePreferredStockSeriesC2NonredeemableOrRedeemableIssuerOptionValue`	-	USD	Point-in-time
Series C2 convertible preferred stock, $.001 par value; 5,000 shares authorized, 3.3 and nil shares issued and outstanding as of December 31, 2018 and 2017, respectively. (Liquidation preference of $3,263 and nil at December 31, 2018 and 2017, respectively).	`ConvertiblePreferredStockSeriesC2NonredeemableOrRedeemableIssuerOptionValue`	$531.00K	USD	Point-in-time
Common stock, $.001 par value; 1,000,000 shares authorized, 2,669 and 62 shares issued and outstanding as of December 31, 2018 and 2017, respectively	`CommonStockValue`	$2.88M	USD	Point-in-time
Common stock, $.001 par value; 1,000,000 shares authorized, 2,669 and 62 shares issued and outstanding as of December 31, 2018 and 2017, respectively	`CommonStockValue`	$791.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$118.26M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$117.42M	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$132.00K	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$132.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-137.63M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-138.53M	USD	Point-in-time
TOTAL STOCKHOLDERS DEFICIT	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-19.40M	USD	Point-in-time
TOTAL STOCKHOLDERS DEFICIT	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-15.82M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$236.00K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$406.00K	USD	Point-in-time

Income Statement 46 line items

Line Item	Tag	Value	Unit	Period
Sales - devices and disposables	`Revenues`	$244.00K	USD	Annual
Sales - devices and disposables	`Revenues`	$57.00K	USD	Annual
Cost of goods sold	`CostOfRevenue`	$89.00K	USD	Annual
Cost of goods sold	`CostOfRevenue`	$530.00K	USD	Annual
Gross (loss) profit	`GrossProfit`	$-286.00K	USD	Annual
Gross (loss) profit	`GrossProfit`	$-32.00K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$244.00K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$334.00K	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$195.00K	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$245.00K	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$1.08M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$2.26M	USD	Annual
Total operating expenses	`OperatingExpenses`	$2.83M	USD	Annual
Total operating expenses	`OperatingExpenses`	$1.52M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-3.12M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-1.55M	USD	Annual
Other income	`OtherIncome`	$18.00K	USD	Annual
Other income	`OtherIncome`	$54.00K	USD	Annual
Interest expense	`InterestExpense`	$1.11M	USD	Annual
Interest expense	`InterestExpense`	$1.76M	USD	Annual
Gain from extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$1.04M	USD	Annual
Gain from extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Change in fair value of warrants	`DerivativeGainLossOnDerivativeNet`	$-6.49M	USD	Annual
Change in fair value of warrants	`DerivativeGainLossOnDerivativeNet`	$3.23M	USD	Annual
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$2.56M	USD	Annual
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$-7.58M	USD	Annual
INCOME (LOSS) BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-10.70M	USD	Annual
INCOME (LOSS) BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.02M	USD	Annual
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	Annual
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	Annual
NET INCOME (LOSS)	`NetIncomeLoss`	$1.02M	USD	Annual
NET INCOME (LOSS)	`NetIncomeLoss`	$-10.70M	USD	Annual
DEEMED DIVIDENDS	`InvestmentIncomeDividend`	-	USD	Annual
DEEMED DIVIDENDS	`InvestmentIncomeDividend`	-	USD	Annual
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$278.00K	USD	Annual
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$116.00K	USD	Annual
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-10.97M	USD	Annual
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$900.00K	USD	Annual
BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasic`	$1.95	USD	Annual
BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasic`	$997.64	USD	Annual
DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareDiluted`	-	USD	Annual
DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareDiluted`	$0.01	USD	Annual
WEIGHTED AVERAGE SHARES OUTSTANDING BASIC	`WeightedAverageNumberOfSharesOutstandingBasic`	11.00	shares	Annual
WEIGHTED AVERAGE SHARES OUTSTANDING BASIC	`WeightedAverageNumberOfSharesOutstandingBasic`	462.00	shares	Annual
WEIGHTED AVERAGE SHARES OUTSTANDING DILUTED	`WeightedAverageNumberOfDilutedSharesOutstanding`	0.00	shares	Annual
WEIGHTED AVERAGE SHARES OUTSTANDING DILUTED	`WeightedAverageNumberOfDilutedSharesOutstanding`	65,227.00	shares	Annual

Cash Flow Statement 57 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$1.02M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-10.70M	USD	Annual
Bad debt expense	`ProvisionForDoubtfulAccounts`	$1.00K	USD	Annual
Bad debt expense	`ProvisionForDoubtfulAccounts`	$174.00K	USD	Annual
Depreciation	`DepreciationDepletionAndAmortization`	$213.00K	USD	Annual
Depreciation	`DepreciationDepletionAndAmortization`	$27.00K	USD	Annual
Amortization of debt issuance costs and discounts	`AmortizationOfFinancingCostsAndDiscounts`	$190.00K	USD	Annual
Amortization of debt issuance costs and discounts	`AmortizationOfFinancingCostsAndDiscounts`	-	USD	Annual
Amortization of beneficial conversion feature	`DebtInstrumentConvertibleBeneficialConversionFeature`	$645.00K	USD	Annual
Amortization of beneficial conversion feature	`DebtInstrumentConvertibleBeneficialConversionFeature`	-	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$59.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$44.00K	USD	Annual
Change in fair value of warrants	`ChangeInFairValueOfWarrants`	$-3.23M	USD	Annual
Change in fair value of warrants	`ChangeInFairValueOfWarrants`	$6.49M	USD	Annual
Gain on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$1.04M	USD	Annual
Gain on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$10.00K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$9.00K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$-508.00K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$-151.00K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-152.00K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-42.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-260.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-41.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$420.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-6.00K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-13.00K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$45.00K	USD	Annual
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$722.00K	USD	Annual
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$1.30M	USD	Annual
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$-2.38M	USD	Annual
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$9.55M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.14M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.36M	USD	Annual
Proceeds from debt financing, net of discount and debt issuance costs	`ProceedsFromIssuanceOfDebt`	-	USD	Annual
Proceeds from debt financing, net of discount and debt issuance costs	`ProceedsFromIssuanceOfDebt`	$1.39M	USD	Annual
Payments made on notes and loans payable	`PaymentsOfLoanCosts`	$441.00K	USD	Annual
Payments made on notes and loans payable	`PaymentsOfLoanCosts`	$192.00K	USD	Annual
Proceeds for future issuance of common stock	`ProceedsForFutureIssuanceOfCommonStock`	$126.00K	USD	Annual
Proceeds for future issuance of common stock	`ProceedsForFutureIssuanceOfCommonStock`	-	USD	Annual
Net proceeds from issuance of common stock and warrants	`ProceedsFromIssuanceOfCommonStock`	$1.57M	USD	Annual
Net proceeds from issuance of common stock and warrants	`ProceedsFromIssuanceOfCommonStock`	$44.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.13M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.36M	USD	Annual
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.00K	USD	Annual
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-13.00K	USD	Annual
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$1.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$14.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of year	`Cash`	-	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of year	`Cash`	$1.00K	USD	Point-in-time
Cash paid for Interest	`InterestPaidNet`	$46.00K	USD	Annual
Cash paid for Interest	`InterestPaidNet`	$116.00K	USD	Annual
Issuance of common stock as debt repayment	`IssuanceOfCommonStockAsDebtRepayment`	$468.00K	USD	Annual
Issuance of common stock as debt repayment	`IssuanceOfCommonStockAsDebtRepayment`	$925.00K	USD	Annual
Dividends on preferred stock	`DividendsOnPreferredStock`	$278.00K	USD	Annual
Dividends on preferred stock	`DividendsOnPreferredStock`	$116.00K	USD	Annual

Stockholders Equity 17 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, Amount	`StockholdersEquity`	$-9.27M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$-19.40M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$-15.82M	USD	Point-in-time
Issuance of warrants with debt	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$20.00K	USD	Annual
Preferred dividends	`DividendsPreferredStock`	$2.00K	USD	Annual
Conversion of Series C preferred stock to common stock, Amount	`ConversionOfSeriesCPreferredStockToCommonStockAmount`	$170.00K	USD	Annual
Conversion of debt into common stock, Amount	`DebtConversionConvertedInstrumentAmount1`	$468.00K	USD	Annual
Conversion of debt into common stock, Amount	`DebtConversionConvertedInstrumentAmount1`	$925.00K	USD	Annual
Issuance of common stock, Amount	`StockIssuedDuringPeriodValueOther`	$47.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$59.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$44.00K	USD	Annual
Forgiveness of debt	`DebtInstrumentDecreaseForgiveness`	$667.00K	USD	Annual
Net income (loss)	`NetIncomeLoss`	$1.02M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-10.70M	USD	Annual
Ending Balance, Amount	`StockholdersEquity`	$-9.27M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$-19.40M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$-15.82M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.